The potential of proton beam radiation therapy in intracranial and ocular tumours

References

• Andersen AP. Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978; 17: 475–84
   PubMed Web of Science ®Google Scholar
• Berg G, Blomquist E, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in brain tumours. Acta Oncol 2003; 42: 582–8
   PubMed Web of Science ®Google Scholar
• Curran WJ, Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704–10
   PubMed Web of Science ®Google Scholar
• Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649–52
   PubMed Web of Science ®Google Scholar
• Sandberg-Wollheim M, Malmstrom P, Stromblad LG, Anderson H, Borgstrom S, Brun A, et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 1991; 68: 22–9
   PubMed Web of Science ®Google Scholar
• Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979; 5: 1725–31
   PubMed Web of Science ®Google Scholar
• Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994; 30: 146–9
   PubMed Web of Science ®Google Scholar
• Liang BC, Weil M. Locoregional approaches to therapy with gliomas as the paradigm. Curr Opin Oncol 1998; 10: 201–6
   PubMedGoogle Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–96
   PubMed Web of Science ®Google Scholar
• Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, et al. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 1998; 16: 2202–12
   PubMed Web of Science ®Google Scholar
• Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, et al. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 1987; 67: 864–73
   PubMed Web of Science ®Google Scholar
• Riva P, Franceschi G, Arista A, Frattarelli M, Riva N, Cremonini AM, et al. Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas: a six-year clinical experience. Cancer 1997; 80: 2733–42
   PubMed Web of Science ®Google Scholar
• Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, et al. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992; 24: 583–91
   PubMed Web of Science ®Google Scholar
• Papagikos MA, Shaw EG, Stieber VW. Lessons learned from randomised clinical trials in adult low grade glioma. Lancet Oncol 2005; 6: 240–4
   PubMedGoogle Scholar
• Blomquist E, Carlsson J. Strategy for planned radiotherapy of malignant gliomas: postoperative treatment with combinations of high dose proton irradiation and tumor seeking radionuclides. Int J Radiat Oncol Biol Phys 1992; 22: 259–63
   PubMedGoogle Scholar
• Fitzek MM, Thornton AF, Rabinov JD, Lev MH, Pardo FS, Munzenrider JE, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999; 91: 251–60
   PubMed Web of Science ®Google Scholar
• Castro JR, Phillips TL, Prados M, Gutin P, Larson DA, Petti PL, et al. Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 1997; 38: 257–61
   PubMedGoogle Scholar
• Castro JR, Saunders WM, Austin-Seymour MM, Woodruff KH, Gauger G, Chen GT, et al. A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: a Northern California Oncology Group Study. Int J Radiat Oncol Biol Phys 1985; 11: 1795–800
   PubMedGoogle Scholar
• Morris GM, Micca PL, Rezvani M, Hopewell JW, Coderre JA. Boron neutron capture therapy: effects of split dose and overall treatment time. J Neurooncol 2001; 52: 101–10
   PubMedGoogle Scholar
• Carlsson J, Forsell-Aronsson E, Mattsson S, Glimelius B. and the Swedish Cancer Society Investigation Group. Radiation therapy through activation of stable nuclides. Acta Oncol 2002;41:629–34.
   PubMed Web of Science ®Google Scholar
• Tatsuzaki H, Gregoire V, Linggood R. Comparative treatment planning: proton vs x-ray beams against glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1992; 22: 265–74
   PubMed Web of Science ®Google Scholar
• Archambeau JO, Slater JD, Slater JM, Tangeman R. Role for proton-beam irradiation in treatment of peciatric CNS malignancies. Int J Radiat Oncol Biol Phys 1992; 22: 287–94
   PubMed Web of Science ®Google Scholar
• Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
   PubMed Web of Science ®Google Scholar
• Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185: 675–86
   PubMedGoogle Scholar
• Forssell-Aronsson E, Kjellén E, Mattsson S, Hellström M. and the Swedish Cancer Society Investigation Group. Medical imaging for improved tumour characterisation, delineation and treatment verification. Acta Oncol 2002;41:604–14.
   PubMed Web of Science ®Google Scholar
• Tovi M, Lilja A, Bergstrom M, Ericsson A, Bergstrom K, Hartman M. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol 1990; 31: 417–29
   PubMed Web of Science ®Google Scholar
• Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5: 303–24
   PubMed Web of Science ®Google Scholar
• Huncharek M. Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma. Anticancer Res 1998; 18: 1935–9
   PubMedGoogle Scholar
• Cancer Incidence in Sweden. Epidemiologiskt Centrum 2003; www.sos.se.
   Google Scholar
• Becks JWF. The recurrence of supratentorial meningiomas after surgery. Acta Neurochir 1988; 95: 3–5
   PubMedGoogle Scholar
• Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986; 26: 461–9
   PubMed Web of Science ®Google Scholar
• Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985; 62: 18–24
   PubMed Web of Science ®Google Scholar
• Bakay RA. Stereotactic radiosurgery in the treatment of brain tumors. Clin Neurosurg 1992; 39: 292–313
   PubMedGoogle Scholar
• Duma CM, Lunsford LD, Kondziolka D, Harsh GRt, Flickinger JC Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery. Neurosurgery 1993;32:699–704; discussion 704–5.
   PubMed Web of Science ®Google Scholar
• Ganz JC, Backlund EO, Thorsen FA. The results of Gamma Knife surgery of meningiomas, related to size of tumor and dose. Stereotact Funct Neurosurg 1993; 61(Suppl 1)23–9
   PubMedGoogle Scholar
• Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from to 1990. J Neurosurg ;80 1967; 1994: 195–201
   Google Scholar
• Helenowski TK, Pothiawala B. Role of the Gamma Knife in the treatment of large lesions. Stereotact Funct Neurosurg 1993; 61(Suppl 1)103–15
   PubMedGoogle Scholar
• Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Stereotactic radiosurgery of meningiomas. J Neurosurg 1991; 74: 552–9
   PubMed Web of Science ®Google Scholar
• Lunsford LD. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?. J Neurosurg 1994; 80: 187–90
   PubMed Web of Science ®Google Scholar
• Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 1999; 90: 42–9
   PubMedGoogle Scholar
• Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E, et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 1999; 141: 933–40
   PubMed Web of Science ®Google Scholar
• Gudjonsson O, Blomquist E, Lilja A, Ericson H, Bergstrom M, Nyberg G. Evaluation of the effect of high-energy proton irradiation treatment on meningiomas by means of 11C-L-methionine PET. Eur J Nucl Med 2000; 27: 1793–9
   PubMedGoogle Scholar
• Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol 2004; 71: 251–8
   PubMed Web of Science ®Google Scholar
• Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol 2003; 68: 1–14
   PubMed Web of Science ®Google Scholar
• Mirimanoff RO. New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Stereotactic radiotherapy? Intensity-modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy. or nothing at all?. Radiother Oncol 2004; 71: 247–9
   PubMedGoogle Scholar
• Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986; 49: 1–10
   PubMed Web of Science ®Google Scholar
• Spetzler RF, Hargraves RW, McCormick PW, Zabramski JM, Flom RA, Zimmerman RS. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992; 76: 918–23
   PubMed Web of Science ®Google Scholar
• Pellettieri L, Carlsson CA, Grevsten S, et al. Surgical versus concervative treatment of intracranial arterivenous malformations. A study in surgical decision-making. Actra Neurochirurgica. Springer-Verlag, Wien, New York 1980
   Google Scholar
• Ogilvy CS. Radiation therapy for arteriovenous malformations: a review. Neurosurgery 1990; 26: 725–35
   PubMed Web of Science ®Google Scholar
• Wolkov HB, Bagshaw M. Conventional radiation therapy in the management of arteriovenous malformations of the central nervous system. Int J Radiat Oncol Biol Phys 1988; 15: 1461–4
   PubMedGoogle Scholar
• Guo WY, Wikholm G, Karlsson B, Lindquist C, Svendsen P, Ericson K. Combined embolization and gamma knife radiosurgery for cerebral arteriovenous malformations. Acta Radiol 1993; 34: 600–6
   PubMed Web of Science ®Google Scholar
• Karlsson B, Lindquist C, Steiner L. Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery 1997;40:425–30; discussion 430–1.
   PubMed Web of Science ®Google Scholar
• Colombo F, Benedetti A, Pozza F, Marchetti C, Chierego G. Linear accelerator radiosurgery of cerebral arteriovenous malformations. Neurosurgery 1989; 24: 833–40
   PubMed Web of Science ®Google Scholar
• Levy RP, Schulte RW, Slater JD, Miller DW, Slater JM. Stereotactic radiosurgery--the role of charged particles. Acta Oncol 1999; 38: 165–9
   PubMedGoogle Scholar
• Steinberg GK, Fabrikant JI, Marks MP, Levy RP, Frankel KA, Phillips MH, et al. Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations. N Engl J Med 1990; 323: 96–101
   PubMed Web of Science ®Google Scholar
• Silander H, Pellettieri L, Enblad P, Montelius A, Grusell E, Vallhagen-Dahlgren C, et al. Fractionated, stereotactic proton beam treatment of cerebral arteriovenous malformations. Acta Neurol Scand 2004; 109: 85–90
   PubMed Web of Science ®Google Scholar
• Vernimmen FJ, Slabbert JP, Wilson JA, Fredericks S, Melvill R. Stereotactic proton beam therapy for intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys 2005; 62: 44–52
   PubMedGoogle Scholar
• Miralbell R, Urie M. Potential improvement of three dimension treatment planning and proton beams in fractionated radiotherapy of large cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys 1993; 25: 353–8
   PubMed Web of Science ®Google Scholar
• Wigg DR. A radiobiological basis for the treatment of arteriovenous malformations. Acta Oncol 1999; 38(Suppl 14)3–29
   PubMedGoogle Scholar
• Wigg DR. Is there a role for fractionated radiotherapy in the treatment of arteriovenous malformations?. Acta Oncol 1999; 38: 979–86
   PubMed Web of Science ®Google Scholar
• al Mefty O, Berby L. Skull base chordomas: a management challenge. J Neurosurg 1997; 86: 287–295
   Google Scholar
• Kondziolka D, Lunsford LD, Flickinger JC. The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery 1991;29:38–45; discussion 45–6.
   PubMed Web of Science ®Google Scholar
• Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 2002; 52: 1017–24
   PubMed Web of Science ®Google Scholar
• Munzenrider JE, Liebsch N. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999; 175((Suppl))257–63
   PubMedGoogle Scholar
• Suit HD, Goitein M, Munzenrider J, Verhey L, Davis KR, Koehler A, et al. Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg 1982; 56: 377–85
   PubMed Web of Science ®Google Scholar
• Igaki H, Tokuuye K, Okumura T, Sugahara S, Kagei K, Hata M, et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004; 60: 1120–6
   PubMed Web of Science ®Google Scholar
• Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91: 432–9
   PubMed Web of Science ®Google Scholar
• Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999; 45: 351–8
   PubMed Web of Science ®Google Scholar
• Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999; 23: 1370–8
   PubMed Web of Science ®Google Scholar
• Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 2000; 11: 627–38
   PubMed Web of Science ®Google Scholar
• Noel G, Habrand JL, Mammar H, Pontvert D, Haie-Meder C, Hasboun D, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys 2001; 51: 392–8
   PubMed Web of Science ®Google Scholar
• Colli B, Al-Mefty O. Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 2001; 95: 933–43
   PubMed Web of Science ®Google Scholar
• Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 1990; 13: 327–30
   PubMed Web of Science ®Google Scholar
• Feuvret L, Noël G, Calugaru V, Terrier P, Habrand J. Chondromyxoid fibroma of the skull base: differential diagnosis and radiotherapy. Two case reports and a review of the literature. Acta Oncol 2005; in press.
   Google Scholar
• Austin JP, Urie MM, Cardenosa G, Munzenrider JE. Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 1993; 25: 439–444
   PubMed Web of Science ®Google Scholar
• Debus J, Haberer T, Schulz-Ertner D, Jakel O, Wenz F, Enghardt W, et al. Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives]. Strahlenther Onkol 2000; 176: 211–6
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Haberer T, Jakel O, Thilmann C, Kramer M, Enghardt W, et al. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions. Int J Radiat Oncol Biol Phys 2002; 53: 36–42
   PubMedGoogle Scholar
• Berson AM, Castro JR, Petti P, Phillips TL, Gauger GE, Gutin P, et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 1988; 15: 559–65
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Larsson DA, Shrieve DC. Radiosurgery for the treatment of intracranial lesions. Important advances in oncology, V HS De Vita, A Rosenberg. Lippincott, Philadelphia 1995; 141–56
   Google Scholar
• McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB, Jr, Rhoton AL, et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997; 39: 437–44
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Stokes S, Marks JE, Simpson JR. Prognostic factors and results of radiotherapy alone in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 1988; 15: 1103–10
   PubMedGoogle Scholar
• Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC. Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 1998;43:432–8; discussion 438–9.
   PubMed Web of Science ®Google Scholar
• Landolt AM, Lomax N. Gamma knife radiosurgery for prolactinomas. J Neurosurg 2000; 93(Suppl 3)14–8
   PubMedGoogle Scholar
• Kjellberg RN, Shintani A, Frantz AG, Kliman B. Proton-beam therapy in acromegaly. N Engl J Med 1968; 278: 689–95
   PubMed Web of Science ®Google Scholar
• Minakova Y, Kerpatorskaya LY, Lyass FM. Proton beam therapy for pituitary adenomas. Med Radial (Moscow) 1983; 28: 7–13
   PubMedGoogle Scholar
• Levy RP, Fabricant JL, Lyman JT. Clinical results of sterotactic heavy-charged particle radiosurgery of the pituitary gland. In:. Steiner et al editor, Radiosurgery: baseline and trends. New York: Raven Press; 1992.
   Google Scholar
• Egger E, Zografos L, Schalenbourg A, Beati D, Bohringer T, Chamot L, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003; 55: 867–80
   PubMed Web of Science ®Google Scholar
• Egger E, Zografos L, Munkel G. Proton beam irradiation of Choroidal melanoma: Technique and Results. Radiation therapy of Intraocular and Orbital Tumors2nd ed, LW Brady, H-P Heilmann, M Molls. Springer Verlag, Berlin 2002; 67–80
   Google Scholar
• Goitein M, Miller T. Planning proton therapy of the eye. Med Phys 1983; 10: 275–83
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002;100:43–8; discussion 48–9.
   PubMedGoogle Scholar
• Munzenrider JE, Gragoudas ES, Seddon JM, Sisterson J, McNulty P, Birnbaum S, et al. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys 1988; 15: 553–8
   PubMed Web of Science ®Google Scholar
• Naeser P, Blomquist E, Montelius A, Thoumas KA. Proton irradiation of malignant uveal melanoma. A five year follow-up of patients treated in Uppsala, Sweden. Ups J Med Sci 1998; 103: 203–11
   PubMed Web of Science ®Google Scholar
• Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003; 56: 544–55
   PubMed Web of Science ®Google Scholar